In the treatment of cancer, the cytotoxic effects of PARPis have various mechanisms, such as competition with NAD+ for the C-terminal catalytic site of the PARP and the trapping of PARP-DNA complexes, which prevents the recruitment of DNA repair proteins. This evidence concerns the gene PARP1 and cancer.